13th Annual Proteins & Antibodies Congress27 - 29 April 2020 | London, UK

Cutting edge discussions on protein & antibody engineering and development strategies, biotherapeutics discovery & development, biologics manufacturing and bioanalytics

The Proteins & Antibodies Congress includes...

Over 450 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions.

Over 80 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production & manufacturing. 

PLUS:

  • Roundtable & Panel Discussions
  • Pre-Event Webinars

Agenda at a Glance

27 April 2019 – Day One (Kick-off Sessions)

  • Protein Engineering, Expression, Design & Selection
  • Bioanalysis: Characterisation, Stability Testing And Formulation Development
  • Biotherapeutics: Discovery & Development – Oncology & Immuno-Oncology

28 April 2020 – Day Two

  • Antibody Engineering, Screening, Design, Development
  • ADC Engineering, Bioconjugates and Fusion Proteins
  • Biotherapeutics: Discovery & Development – Oncology & Immuno-Oncology

29 April 2020 – Day Three

  • Antibody Engineering, Development & Generation (Part 1) and Biotherapeutics: Discovery & Development–Non-Oncology Indications (Part 2)
  • Bioanalysis: PKPD & Manufacturing
  • Biotherapeutics: Discovery & Development – Non-Oncology Indications